Jun 08, 2022 / 06:00PM GMT
Akash Tewari - Jefferies LLC, Research Division - Equity Analyst
All righty. Good afternoon, everyone. I hope you're all enjoying the conference so far. It's really good to be back in person, I will tell you that much.
My name is Akash Tewari. I'm a biotech analyst here at Jefferies. I have the pleasure of hosting the Jazz management team today.
Joining us is Renee Gala, CFO; John Miller, Global Product Strategy and Program Management Head; Dan Swisher, President of Jazz; and then Josh Steinerman, VP of Neuropsychiatry. Thanks so much for joining us.
Maybe, Renee, do you want me to give it to you for some introductory remarks, and then we can get into any specific questions?
Renee D. Gala - Jazz Pharmaceuticals plc - Executive VP & CFO
Sure. That's sounds great. So thank you for having us. It's a pleasure to be here and super exciting to be in person as well.
So just before we get started though, I'll remind you all, we will be making forward-looking statements today. Please consult our website for our SEC filings and
Jazz Pharmaceuticals PLC at Jefferies Healthcare Conference Transcript
Jun 08, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers